loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for 1,4-Pregnadiene-3,20-dione-11-beta,17-alpha,21-triol

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Athena Prednisolone

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    1,4-Pregnadiene-3,20-dione-11-.beta.,17-.alpha.,21-triol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,536Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of June 19, 2024
    Enforcement Report - Week of June 19, 2024

    19 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2024-84054.pdf

    FDA
    19 Jun 2024
    Share Share
    Sparrow Presents Clofutriben Data In PMR At EULAR 2024
    Sparrow Presents Clofutriben Data In PMR At EULAR 2024

    14 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240615894947/en

    BUSINESSWIRE
    14 Jun 2024
    Share Share
    Zhejiang Xianju's Generic Prednisolone Receives Approval in the U.S.
    Zhejiang Xianju's Generic Prednisolone Receives Approval in the U.S.

    02 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218083

    FDA
    02 May 2024
    Share Share
    LYNPARZA Plus Abiraterone and Prednisone or Prednisolone Approved in Japan
    LYNPARZA Plus Abiraterone and Prednisone or Prednisolone Approved in Japan

    24 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230824404671/en

    BUSINESSWIRE
    24 Aug 2023
    Share Share
    Health Canada approves Lynparza with abiraterone for patients with BRCA mCRPC
    Health Canada approves Lynparza with abiraterone for patients with BRCA mCRPC

    14 Jul 2023

    // BIOSPACE

    https://www.biospace.com/article/releases/health-canada-approves-lynparza-in-combination-with-abiraterone-and-prednisone-or-prednisolone-for-patients-with-brca-mutated-metastatic-castration-resistant-prostate-cancer/

    BIOSPACE
    14 Jul 2023
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share